Home » Topics » Regulatory

Regulatory
RSS

Caroverine shown to effective treatment for alcohol withdrawal syndrome

Sep. 22, 1998

Another treatment option added to the anti-HIV arsenal: efavirenz gets FDA approval

Sep. 21, 1998

Orion receives EU approval to market Parkinson's disease treatment

Sep. 21, 1998

Early 1999 launch dates anticipated for EchoGen in European markets

Sep. 18, 1998

Novel use for a known antidepressant: doxepin relieves pruritus in patients with eczema

Sep. 18, 1998

Nasal calcitonin reduces spinal fractures in postmenopausal women with osteoporosis

Sep. 17, 1998

FDA clears diagnostic for DVT - a potentially life-threatening disorder

Sep. 16, 1998

Pylorid-containing triple therapy effective in eradicating H. pylori

Sep. 16, 1998

Hycamtin receives first approval for small cell lung cancer in Switzerland

Sep. 15, 1998

FDA approves, HMR begins shipping new treatment for adult rheumatoid arthritis

Sep. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...